Affiliation:
1. MARMARA UNIVERSITY
2. UNIVERSITY OF HEALTH SCIENCES
Abstract
Crohn’s disease (CD), which can be localized in any part of the gastrointestinal tract, is a disease characterized by an irregular immune
response to normal and/or abnormal microbial antigens. Recent studies show many extensive data about the roles of genetic and
environmental factors, immune function, and gut microbiota in CD. Although, less invasive biomarkers are currently being developed,
the diagnosis of the disease is still based on the endoscopy and histological evaluation of biopsy samples. The most common symptoms
are diarrhea, abdominal pain, weight loss, and fatigue. Despite the improvements in the treatment methods in the last decade, there
is no definitive treatment since the etiology of CD is not known exactly. Therapeutic strategies focus on reducing inflammation and
symptoms, maintaining clinical remission, and improving quality of life.
Reference50 articles.
1. [1] Balmus IM, Ciobica A, Trifan A, Stanciu C. The implications
of oxidative stress and antioxidant therapies in inflammatory
bowel disease: Clinical aspects and animal models. Saudi J
Gastroenterol 2016;22:3-17. doi:10.4103/1319-3767.173753.
2. [2] Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and
prevalence of inflammatory bowel disease in the 21st century:
a systematic review of population-based studies. Lancet
2017;390:2769-78. doi: 10.1016/S0140-6736(17)32448-0.
3. [3] GBD-2017 Inflammatory Bowel Disease Collaborators.
The global, regional, and national burden of inflammatory
bowel disease in 195 countries and territories, 1990-2017: a
systematic analysis for the Global Burden of Disease Study
2017. Lancet Gastroenterol Hepatol 2020;5:17-30. doi:
10.1016/S2468-1253(19)30333-4.
4. [4] Saka M, Koseler E, and Metin S. Gastrointestinal system
diseases and nutrition therapy. In: Tufekci Alphan E, ed.
Nutrition therapy in diseases. Ankara: Hatiboğlu Yayıncılık,
2018:541-638.
5. [5] Buran T. Inflammatory bowel disease; epidemiology, prevalence,
incidence. Turkiye Klinikleri J Gastroenterohepatol-Special
Topics 2017;10:15-7.